PVCT – provectus biopharms (US:NASDAQ)
Stock Stats
News
Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy [Yahoo! Finance]
Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy
Provectus Biopharmaceuticals Initiates Preclinical Study of Oral PV-10 in Bladder Cancer
Form SCHEDULE 13D/A PROVECTUS BIOPHARMACEUTI Filed by: Pershing Edward
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 26 Filed by: Pershing Edward
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 20 Filed by: Pershing Edward
Form 4 PROVECTUS BIOPHARMACEUTI For: Nov 13 Filed by: Pershing Edward
Form 10-Q PROVECTUS BIOPHARMACEUTI For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.